These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14564227)

  • 1. Combining natriuretic peptides and necrosis markers in the assessment of acute coronary syndromes.
    de Lemos JA; Morrow DA
    Rev Cardiovasc Med; 2003; 4 Suppl 4():S37-46. PubMed ID: 14564227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of chest pain and heart failure in the emergency department: impact of multimarker strategies and B-type natriuretic peptide.
    Gibler WB; Blomkalns AL; Collins SP
    Rev Cardiovasc Med; 2003; 4 Suppl 4():S47-55. PubMed ID: 14564228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic and prognostic significance of cardiac biomarkers in patients with the acute coronary syndrome].
    Matunović R; Stojanović A; Mijailović Z; Rabrenović M
    Srp Arh Celok Lek; 2006; 134(3-4):162-5. PubMed ID: 16915760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers.
    Palazzuoli A; Iovine F; Gallotta M; Nuti R
    Minerva Cardioangiol; 2007 Aug; 55(4):491-6. PubMed ID: 17653025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes.
    Wiviott SD; de Lemos JA; Morrow DA
    Clin Chim Acta; 2004 Aug; 346(2):119-28. PubMed ID: 15256312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Troponin is more useful than creatine kinase in predicting one-year mortality among acute coronary syndrome patients.
    Yan AT; Yan RT; Tan M; Chow CM; Fitchett D; Stanton E; Langer A; Goodman SG;
    Eur Heart J; 2004 Nov; 25(22):2006-12. PubMed ID: 15541836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
    Heeschen C; Hamm CW; Mitrovic V; Lantelme NH; White HD;
    Circulation; 2004 Nov; 110(20):3206-12. PubMed ID: 15533869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure.
    Fonarow GC; Horwich TB
    Rev Cardiovasc Med; 2003; 4 Suppl 4():S20-8. PubMed ID: 14564225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac markers for assessing the acute coronary syndromes. A focus on cardiac troponins.
    Saadeddin SM; Habbab MA; Ferns GA
    Saudi Med J; 2000 Mar; 21(3):228-37. PubMed ID: 11533790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troponins in acute coronary syndromes.
    Scirica BM; Morrow DA
    Semin Vasc Med; 2003 Nov; 3(4):363-74. PubMed ID: 15199443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Redefinition of myocardial infarction--relevance of biomarkers].
    Weber M; Hamm C
    Herz; 2008 Mar; 33(2):115-21. PubMed ID: 18344030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide and multimarker approaches in cardiovascular medicine.
    McCullough PA; Fonarow GC
    Rev Cardiovasc Med; 2003; 4 Suppl 4():S1-2. PubMed ID: 14703686
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
    Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
    Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute coronary syndrome: the risk of being female.
    Elsaesser A; Hamm CW
    Circulation; 2004 Feb; 109(5):565-7. PubMed ID: 14769676
    [No Abstract]   [Full Text] [Related]  

  • 16. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardization of cardiac markers.
    Apple FS
    Scand J Clin Lab Invest Suppl; 2005; 240():107-11. PubMed ID: 16112967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
    J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy.
    James SK; Lindbäck J; Tilly J; Siegbahn A; Venge P; Armstrong P; Califf R; Simoons ML; Wallentin L; Lindahl B
    J Am Coll Cardiol; 2006 Sep; 48(6):1146-54. PubMed ID: 16978997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guidelines: acute coronary syndrome (ACS). 1: ACS without persistent ST segment elevations].
    Hamm CW;
    Z Kardiol; 2004 Jan; 93(1):72-90. PubMed ID: 14740245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.